HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells.

Abstract
Caspase function is known to be essential for cell death by apoptosis, but it is now increasingly recognized that these proteases also play important roles in other cellular events. Here we report for the first time that inhibition of cellular caspase activity can induce differentiation of AML blasts, and can enhance vitamin D-induced cell differentiation of these cells. This was studied in blasts obtained from nine patients with AML and one patient with CML by ex vivo culture in the presence of Q-VD-OPh (QVD), a pan caspase inhibitor. Cell differentiation was manifested by the expression of markers of monocytic differentiation CD11b and CD14. Differentiation induced by 1α,25-dihydroxyvitamin D3 (1,25D) or its analogs PRI-1906 and PRI-2191 was enhanced by QVD to a varying degree, depending on the subtype of the leukemia. QVD and 1,25D-induced differentiation was accompanied by increased signaling by Hematopoietic Progenitor Kinase 1(HPK1), and the expression of transcription factors known to be involved in monocytic differentiation was increased. Although the magnitude and nature of these changes were not invariable, it is clear that caspase inhibitors warrant attention as components of differentiation therapy of leukemia, perhaps in combination with derivatives of vitamin D.
AuthorsXiangwen Chen-Deutsch, Andrzej Kutner, Jonathan S Harrison, George P Studzinski
JournalLeukemia research (Leuk Res) Vol. 36 Issue 7 Pg. 884-8 (Jul 2012) ISSN: 1873-5835 [Electronic] England
PMID22541691 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Amino Acid Chloromethyl Ketones
  • Antineoplastic Agents
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Quinolines
  • quinoline-val-asp(OMe)-CH2-OPH
  • Vitamin D
  • hematopoietic progenitor kinase 1
  • Protein Serine-Threonine Kinases
Topics
  • Adult
  • Aged
  • Amino Acid Chloromethyl Ketones (administration & dosage, pharmacology)
  • Antineoplastic Agents (administration & dosage, pharmacology)
  • Caspase Inhibitors
  • Cell Differentiation (drug effects, genetics)
  • Cohort Studies
  • Cysteine Proteinase Inhibitors (administration & dosage, pharmacology)
  • Drug Evaluation, Preclinical
  • Drug Interactions
  • Female
  • Gene Expression Regulation, Leukemic (drug effects)
  • Humans
  • Leukemia, Myeloid, Acute (genetics, metabolism, pathology)
  • Male
  • Middle Aged
  • Protein Serine-Threonine Kinases (genetics, metabolism, physiology)
  • Quinolines (administration & dosage, pharmacology)
  • Signal Transduction (drug effects, genetics, physiology)
  • Tumor Cells, Cultured
  • Up-Regulation (drug effects)
  • Vitamin D (administration & dosage, analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: